DERIVATIVES OF TYPE 1

1986 ◽  
Vol 12 (1) ◽  
pp. 354
Author(s):  
Preise ◽  
Šverák
Keyword(s):  
2006 ◽  
Vol 84 (10) ◽  
pp. 1294-1300 ◽  
Author(s):  
Keith Vaughan ◽  
Shasta Lee Moser ◽  
Reid Tingley ◽  
M Brad Peori ◽  
Valerio Bertolasi

Reaction of a series of diazonium salts with a mixture of formaldehyde and 1,2-diamino-2-methylpropane affords the 3-({5,5-dimethyl-3-[2-aryl-1-diazenyl]-1-imidazolidinyl}methyl)-4,4-dimethyl-1-[2-aryl-1-diazenyl]imidazolidines (1a–1f) in excellent yield. The products have been characterized by IR and NMR spectroscopic analysis, elemental analysis, and X-ray crystallography. The X-ray crystal structure of the p-methoxycarbonyl derivative (1c) establishes without question the connectivity of these novel molecules, which can be described as linear bicyclic oligomers with two imidazolidinyl groups linked together by a one-carbon spacer. This is indeed a rare molecular building block. The molecular structure is corroborated by 1H and 13C NMR data, which correlates with the previously published data of compounds of types 5 and 6 derived from 1,3-propanediamine. The triazene moieties in the crystal of 1c display significant π conjugation, which gives the N—N bond a significant degree of double-bond character. This in turn causes restricted rotation around the N—N bond, which leads to considerable broadening of signals in both the 1H and 13C NMR spectra. The molecular ion of the p-cyanophenyl derivative (1b) was observed using electrospray mass spectrometry (ES + Na). The mechanism of formation of molecules of type 1 is proposed to involve diazonium ion trapping of the previously unreported bisimidazolidinyl methane (13).Key words: triazene, bistriazene, imidazolidine, synthesis, X-ray crystallography, NMR spectroscopy.


Acta Naturae ◽  
2013 ◽  
Vol 5 (1) ◽  
pp. 63-72 ◽  
Author(s):  
S. P. Korolev ◽  
O. V. Kondrashina ◽  
D. S. Druzhilovsky ◽  
A. M. Starosotnikov ◽  
M. D. Dutov ◽  
...  

Human immunodeficiency virus type 1 integrase is one of the most attractive targets for the development of anti-HIV-1 inhibitors. The capacity of a series of 2,1,3-benzoxadiazoles (benzofurazans) and their N-oxides (benzofuroxans) selected using the PASS software to inhibit the catalytic activity of HIV-1 integrase was studied in the present work. Only the nitro-derivatives of these compounds were found to display inhibitory activity. The study of the mechanism of inhibition by nitro-benzofurazans/benzofuroxans showed that they impede the substrate DNA binding at the integrase active site. These inhibitors were also active against integrase mutants resistant to raltegravir, which is the first HIV-1 integrase inhibitor approved for clinical use. The comparison of computer-aided estimations of the pharmacodynamic and pharmacokinetic properties of the compounds studied and raltegravir led us to conclude that these compounds show promise and need to be further studied as potential HIV-1 integrase inhibitors.


2010 ◽  
Vol 88 (4) ◽  
pp. 344-351 ◽  
Author(s):  
Naomi Hunter ◽  
Keith Vaughan

A series of 1,4-di-[2-aryl-1-diazenyl]-2,6-dimethylpiperazines (5a–5l), have been synthesized by the reaction of 2,6-dimethylpiperazine with 2 equiv. of the appropriate diazonium salt. The products have been characterized by IR and NMR spectroscopy, and the molecular composition has been verified by high-resolution EI mass spectrometry with accurate mass measurement of the molecular ion. The presence of stereocenters at C2 and C6 of the piperazine ring in the bis-triazene 5 creates two unique pairs of diastereotopic protons in the methylene groups at positions 3 and 5 of the piperazine ring, as evidenced by the complexity of the NMR spectra, which nevertheless can be fully assigned in most cases. The assignment of the proton and carbon signals in the 1,4-di-[2-aryl-1-diazenyl]-2,6-dimethylpiperazines has been aided by the use of 2D NMR HSQC spectroscopy. These results compare favorably with assignments of proton and carbon signals reported previously for triazenes of type 1 and bis-triazenes of type 3.


2004 ◽  
Author(s):  
Nikolay S. Pivnenko ◽  
Alexander I. Krivoshey ◽  
Lidiya A. Kutulya ◽  
V. I. Musatov

2011 ◽  
Vol 90 (2) ◽  
pp. A44-A45
Author(s):  
Kamelia R. Stanoeva ◽  
Ivanka G. Stankova ◽  
Anton V. Hinkov ◽  
Ivailo I. Alexiev ◽  
Petya D. Genova-Kalou ◽  
...  

2004 ◽  
Vol 19 (1) ◽  
pp. 33-38 ◽  
Author(s):  
Adnan A. Bekhit ◽  
Ola A. El-Sayed ◽  
Hassan Y. Aboul-Enein ◽  
Yunus M. Siddiqui ◽  
Mohammed N. Al-Ahdal

Sign in / Sign up

Export Citation Format

Share Document